BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Beckman Coulter, Inc. (BEC) (Jobs) in Pact with Alverno Clinical Laboratories, LLC


9/27/2007 7:44:04 AM

FULLERTON, Calif., Sept. 27 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. , a leading manufacturer of diagnostics instruments in the U.S., announced it has been awarded a sole-source agreement with Alverno Clinical Laboratories, LLC, to provide a full range of hematology analyzers and supplies. Alverno is an integrated laboratory services provider jointly sponsored by Sisters of St. Francis Health Services and Provena Health, with 18 hospitals and four laboratories in Illinois and Indiana.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

If all terms of the agreement are fulfilled, Alverno is expected to purchase approximately $10 million over the life of the contract. This contract covers all locations, including some that were recently added to the group through mergers with Provena Health and the Sisters of St. Francis Health Services. These locations will replace existing systems with Beckman Coulter products to achieve standardization of testing platforms throughout the network.

"Beckman Coulter is a valued business partner and the relationship is important to our success," said Sam Terese, Alverno Clinical Laboratories Chief Operating Officer. "We are very comfortable with the technology, reliability and capabilities of the Beckman Coulter hematology line, but beyond these requirements, we look to our business partners to evaluate our operations and add value by ensuring we are using their products as effectively and productively as possible."

Scott Garrett, Beckman Coulter president and CEO said, "We are pleased that Alverno will offer its members hematology instrument systems and supplies from Beckman Coulter. Our innovative solutions will help Alverno facilities simplify and automate their processes to further increase their laboratories' efficiency, helping to lower overall healthcare costs."

About Alverno Clinical Laboratories, LLC

An integrated laboratory services provided jointly sponsored by Sisters of St. Francis Health Services (SSFHS) and Provena Health, Alverno's goal is to become one of the area's most advanced and dynamic clinical laboratory providers. The integration will enable their laboratory organization to provide a higher quality of laboratory science and service and to compete better in the future. When operations are fully integrated, the network will serve 18 hospitals in Illinois and Indiana, and dozens of clinics and health centers, approaching a volume of 10 million tests annually.

About Beckman Coulter, Inc.

Based in Fullerton, California, Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue consisting of supplies, test kits, service and operating-type lease payments represents more than 75 percent of the company's 2006 annual revenue of $2.53 billion. For more information, visit http://www.beckmancoulter.com.

Contacts: Mary Luthy, Beckman Coulter Robert Raynor, Beckman Coulter

Corporate Communications Investor Relations (714) 993-8770 (714) 773-7620

Photo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGOPRN Photo Desk, photodesk@prnewswire.comBeckman Coulter, Inc.

CONTACT: Mary Luthy, Corporate Communications, +1-714-993-8770, or RobertRaynor, Investor Relations, +1-714-773-7620, both of Beckman Coulter



Read at Reuters
Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES